Incretin Drugs and Muscle Loss: Why Lean Mass Decline May Not Mean Sarcopenia
A new perspective in Advances in Therapy argues that lean mass loss during incretin therapy reflects physiological body composition remodeling ...
A new perspective in Advances in Therapy argues that lean mass loss during incretin therapy reflects physiological body composition remodeling ...
A new review proposes a hierarchical nutritional framework inspired by the traditional Chinese medicine concept of Jun-Chen-Zuo-Shi to individualize the ...
A new review finds that muscle mass, fat distribution, and sarcopenic obesity strongly influence chemotherapy toxicity in early-stage breast cancer, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine